COVID-19 vaccine anaphylaxis: PEG or not?
Allergy
.
2021 Jun;76(6):1934-1937.
doi: 10.1111/all.14722.
Authors
Matthew S Krantz
1
,
Yiwei Liu
2
,
Elizabeth J Phillips
3
4
,
Cosby A Stone Jr
1
Affiliations
1
Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
2
Pharmaceutical Sciences Department, St. Jude Children's Research Hospital, Memphis, TN, USA.
3
Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
4
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
PMID:
34128562
PMCID:
PMC8441754
DOI:
10.1111/all.14722
No abstract available
Publication types
Letter
Comment
MeSH terms
Anaphylaxis* / diagnosis
Anaphylaxis* / etiology
COVID-19 Vaccines
COVID-19*
Humans
Polyethylene Glycols
SARS-CoV-2
Substances
COVID-19 Vaccines
Polyethylene Glycols
Grants and funding
K12 HS026395/HS/AHRQ HHS/United States